Financing ·
Mesoblast Limited's Founder and CEO, Dr. Silviu Itescu, exercised 1,885,334 options at a price of A$1.45 per share…
MEOBFMesoblast Ltd
Mesoblast Limited's Founder and CEO, Dr. Silviu Itescu, exercised 1,885,334 options at a price of A$1.45 per share, making a total payment of A$2,733,734. Following this transaction, Dr. Itescu's total shareholding increased to 80,844,262 ordinary shares. The CEO did not sell any of the newly acquired shares. Mesoblast is a biotechnology company that develops allogeneic cellular medicines for inflammatory diseases.